Mesenchymal Stem Cells from Familial Alzheimer’s Patients Express MicroRNA Differently
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the predominant form of dementia globally. No reliable diagnostic, predictive techniques, or curative interventions are available. MicroRNAs (miRNAs) are vital to controlling gene expression, making them valuable biomarkers for...
Main Authors: | Lory J. Rochín-Hernández, Lory S. Rochín-Hernández, Mayte L. Padilla-Cristerna, Andrea Duarte-García, Miguel A. Jiménez-Acosta, María P. Figueroa-Corona, Marco A. Meraz-Ríos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/3/1580 |
Similar Items
-
The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer’s Disease Reveals New Insights for AD Study
by: Lory J. Rochín-Hernández, et al.
Published: (2023-08-01) -
A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
by: Rosanna Tortelli, et al.
Published: (2021-06-01) -
Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer’s Disease
by: Nima Sanadgol, et al.
Published: (2023-09-01) -
New Insights into the Molecular Bases of Familial Alzheimer’s Disease
by: Valeria D’Argenio, et al.
Published: (2020-04-01) -
miR-3940-5p reduces amyloid β production via selectively targeting PSEN1
by: Yanmei Qi, et al.
Published: (2024-03-01)